Microbot Medical (MBOT) has issued an update.
Microbot Medical Inc. has achieved ISO 13485:2016 certification for its quality management system, a critical step for marketing its products in the European Union and aligning with the U.S. FDA’s updated regulations. This milestone could streamline the company’s regulatory compliance and is part of a forward-looking strategy that includes future regulatory goals. However, the company cautions that these projections are subject to change and are not guaranteed.
See more data about MBOT stock on TipRanks’ Stock Analysis page.
